HIPERPROLACTINEMIA ARTICULO PDF
Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf), 48 () . La presencia de macroprolactina sérica es un hecho relativamente frecuente que puede conducir a exploraciones costosas y tratamientos ineficaces. Manejo terapéutico de la hiperprolactinemia. Therapeutic management of hyperprolactinemia. Visits. J M. Cabezas Agrícolaa, J. Cabezas-Cerratoa.
|Published (Last):||5 October 2004|
|PDF File Size:||19.3 Mb|
|ePub File Size:||6.95 Mb|
|Price:||Free* [*Free Regsitration Required]|
Previous article Next article. The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis. Method for detection and clinical characterization of the entity in 39 patients.
Continuing navigation will be considered as acceptance of this use. J Clin Endocrinol Metab, 68pp. Surgical treatment of prolactin-secreting pituitary adenomas: Endocrinol Nutr, 51pp. Full text is only aviable in PDF. Low doses of dopamine agonists in hiperprolactineima longterm treatment of macroprolactinomas. Clin Endocrinol Oxf37pp. CiteScore measures average citations received per document published. Scand J Clin Lab Invest, 44pp.
Am Fam Physician, 72pp. Subscribe to our Newsletter.
Hiperprolactinemia por macroprolactina y disfunción eréctil | Endocrinología y Nutrición
J Clin Endocrinol Metab, 62pp. Si continua navegando, consideramos que acepta su uso. It has a limited relation with the clinical findings and there should always be sought other articuol causes of this situation.
From Monday to Friday from 9 hiperprolactniemia. Reprod Toxicol, 16pp. Clin Exp Rheumatol, 19pp. Selective stimulation of collagen synthesis in the presence of co-stimulatory insulin signalling by connective tissue growth factor in scleroderma fibroblasts. Clinical significance of fibromyalgia syndrome in different A case of progressive systemic sclerosis PSS with silent thyroiditis and anti-bovine thyrotropin antibodies. Urology, 49pp.
The natural history of untreated hyperprolactinemia: Frequency of hyperprolactinaemia due to large molecular weight prolactin kD PRL. It is important to run thyroid function test and to investigate the manifestation of clinical and subclinical hypothyroidism and to initiate treatment with levothyroxine.
Endocrinol Metab Clin North Am, 30pp. It is an apparently benign situation and its identification can avoid unnecessary explorations and treatments. The journal fully endorses the goals of updating knowledge and hiperporlactinemia the acquisition of key developments in internal medicine applied to clinical practice. Clin Rheumatol, 25pp. Are you a health professional able to prescribe or dispense drugs? Treatment was discontinued because of discomfort, and prolactin concentrations were persistently elevated.
Subscribe to our Newsletter. Clin Exp Rheumatol, 15pp. Role of estrogens in the management of postmenopausal bone loss. Risks and benefits of estrogens plus progestin in healthy postmenopausal women: Rheumatology, 38pp.
Previous article Next article. Hospital de Especialidades Dr. Chronic autoimmune thyroiditis and rheumatic manifestations. For it the hiperprolactinnemia history of all the cases in which there was detected macroprolactinemia, some of them with several years of previous follow-up, was reviewed exhaustively.
Endocrinol Nutr, 50pp. Structural variants of prolactin: Prospective evaluation of thyroid function in patients with systemic sclerosis scleroderma.
Rev Assoc Med Bras, 43pp.
Show more Show less. Other structural causes of hyperprolactinemia include non-functioning pituitary adenomas and infiltrative disorders, which can interrupt the inhibitory, descending dopaminergic tone.
[Current diagnosis and treatment of hyperprolactinemia].
Clinical and biological characterization of macroprolactinemia with and without prolactin- IgG complexes. Rheum Dis Clin North Am, 27hipefprolactinemia. Full text is only aviable in PDF.
SJR uses a similar algorithm as the Google page rank; hiperpropactinemia provides a quantitative and qualitative measure of the journal’s impact. Osteopenia in systemic sclerosis: